The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Gold nanoparticles: Emerging paradigm for targeted drug delivery system
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 2×
“…N C O R R E C factor-1(GF-1), phosphatidylinositol 3-kinases (PI3K) andmitogen activated protein kinases (MAPK) signaling pathway, whichwere generally considered as carcinogenic (Cairns et al., 2011; Vander Heiden et al., 2009).”
BackgroundDrug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 1×
“For instance, drug localization, decreased side effects, reduced dosage, modulated pharmacokinetics, controlled biodistribution, and most importantly, improved patient's compliance (Allen and Cullis, 2004; Farokhzad and Langer, 2009).”
Background
Cited by
Recent biomedical applications of gold nanoparticles: A review
Elahi, N., Kamali, M., & Baghersad, M. H. (2018) · Talanta · doi:10.1016/j.talanta.2018.02.088 · Cited by 1,174
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications
Kong, F.-Y., Zhang, J.-W., Li, R.-F., Wang, Z.-X., Wang, W.-J., & Wang, W. (2017) · Molecules · doi:10.3390/molecules22091445 · Cited by 615
Review on nanomaterials: Synthesis and applications
Kolahalam, L. A., Kasi Viswanath, I. V., Diwakar, B. S., Govindh, B., Reddy, V., & Murthy, Y. L. N. (2019) · Materials Today: Proceedings · doi:10.1016/j.matpr.2019.07.371 · Cited by 592
Zaleska-Medynska, A., Marchelek, M., Diak, M., & Grabowska, E. (2016) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.12.008 · Cited by 540
Three-dimensional in vitro tumor models for cancer research and drug evaluation
Xu, X., Farach-Carson, M. C., & Jia, X. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.009 · Cited by 461
Austin, L. A., Mackey, M. A., Dreaden, E. C., & El-Sayed, M. A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1245-3 · Cited by 427
Green synthesis of gold nanoparticles using plant extracts as reducing agents
Zeiri, Y., Elia, P., Zach, R., Hazan, S., Kolusheva, S., & Porat, Z. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s57343 · Cited by 401
Chen, W., Chang, H., Lu, J., Huang, Y., Harroun, S. G., Tseng, Y., Li, Y., Huang, C., & Chang, H. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201503248 · Cited by 298
Uptake of Engineered Gold Nanoparticles into Mammalian Cells
Dykman, L. A., & Khlebtsov, N. G. (2014) · Chemical Reviews · doi:10.1021/cr300441a · Cited by 292
Ultrasmall gold nanoparticles in cancer diagnosis and therapy
Fan, M., Han, Y., Gao, S., Yan, H., Cao, L., Li, Z., Liang, X.-J., & Zhang, J. (2020) · Theranostics · doi:10.7150/thno.42471 · Cited by 277
Self-citationRecent Advances in light-responsive on-demand drug-delivery Systems
Linsley, C. S., & Wu, B. M. (2017) · Therapeutic Delivery · doi:10.4155/tde-2016-0060 · Cited by 265
Gold nanoparticles enlighten the future of cancer theranostics
Guo, J., Rahme, K., He, Y., Li, L.-L., Holmes, J., & O'Driscoll, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140772 · Cited by 260
Current trends in using polymer coated gold nanoparticles for cancer therapy
Muddineti, O. S., Ghosh, B., & Biswas, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.038 · Cited by 259
Nanodrug delivery in reversing multidrug resistance in cancer cells
Yergeri, M., Kapse-Mistry, S., Srivastava, R., & Govender, T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00159 · Cited by 255
Recent Formulation Advances of Mangiferin
Barakat, S., Nasr, M., Ahmed, R. F., Badawy, S., & Mortada, N. (2022) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-022-00297-z · Cited by 28
“Gold nanoparticles are metallic particles which are non-toxic, biocompatible, with macroscopic quantum tunneling effect, distinct surface effect, ultra-small size, and surface plasmon resonance (SPR) bands (Hainfeld et al. 2005; Kumar et al. 2013).”
BackgroundVishwakarma, K. K., Hafeez, A., Usmani, S. A., Noor, L., & Khan, I. R. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010318524240907135527 · Cited by 4
Metadata
- Authors
- Kumar, A., Zhang, X., & Liang, X.-J.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 31
- Issue
- 5
- Pages
- 593-606
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2075585703
- Cited by
- 371
- References
- 198
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.